[HTML][HTML] Management of uterine sarcomas and prognostic indicators: real world data from a single-institution

A Kyriazoglou, M Liontos, DC Ziogas, F Zagouri… - BMC cancer, 2018 - Springer
Background Uterine sarcomas consist a heterogeneous group of mesenchymal
gynecological malignancies with unclear therapeutic recommendations and unspecific but …

[HTML][HTML] Identification of somatic genetic alterations using whole-exome sequencing of uterine leiomyosarcoma tumors

L Chen, J Li, X Wu, Z Zheng - Frontiers in Oncology, 2021 - frontiersin.org
Background The genomic abnormalities associated with uterine leiomyosarcoma (uLMS)
have not been fully elucidated to date. Objective To understand the pathogenesis of uLMS …

Secondary cytoreductive surgery in recurrent uterine leiomyosarcoma: A multi-institutional study

N Bizzarri, V Ghirardi, GLM Di Fiore… - International Journal of …, 2019 - ijgc.bmj.com
Introduction Uterine leiomyosarcoma (uLMS) represents a rare gynecological malignancy
with high incidence of recurrence. Evidence in literature about the management of recurrent …

[HTML][HTML] Development of a multi-institutional prediction model for three-year survival status in patients with uterine leiomyosarcoma (AGOG11-022/QCGC1302 study)

KY Tse, RWC Wong, A Chao, SH Ueng, LY Yang… - Cancers, 2021 - mdpi.com
Simple Summary Uterine leiomyosarcoma is an aggressive tumor and the current staging
system cannot differentiate the patients into different prognostic groups. This leads to …

MULTIPLE INTERVAL DEBULKING SURGERY IN RECURRENT UTERINE SARCOMA (CASE REPORT).

S Chetverikov, V Maksymovskyi, D Atanasov… - Georgian Medical …, 2021 - europepmc.org
We report a case of a 61-year-old woman, who had been suffering from multiple relapses of
uterine sarcoma treated by multiple cytoreduction operations. During the observation period …

Development and validation of tumor‐size‐stratified prognostic nomograms for patients with uterine sarcoma: A SEER database analysis

S Cao, X Liao, K Xu, H Xiao, Z Shi, Y Zou, C Li… - Cancer …, 2023 - Wiley Online Library
Background Tumor‐size‐stratified analysis on the prognosis of uterine sarcoma is
insufficient. This study aimed to establish the tumor‐size‐stratified nomograms to predict the …

[PDF][PDF] Clinical characteristics of uterine sarcoma: Retrospective analysis of a single center

S Alemdaroglu, SY Baran, SY Simsek… - …, 2021 - manage.effectpublishing.com
To examine the histopathological features and treatment modalities in patients with uterine
sarcoma according to subgroups (uterine leiomyosarcoma, low grade/high grade …

Favorable factors affecting the prognosis of recurrent uterine leiomyosarcoma

이은지 - 2021 - s-space.snu.ac.kr
Introduction: To evaluate favorable prognostic factors related to the prognosis of recurrent
uterine leiomyosarcoma (uLMS). Materials and Methods: The database searched those …

Uterine sarcomas: 7-year experience from a tertiary center

MH Yetimalar, D Kılıç, S Yigit - Current Gynecologic Oncology, 2020 - gcris.pau.edu.tr
Uterine sarcomas are rare and aggressive gynecologic malignancies. Due to their rarity,
histopathologic heterogeneity and molecular diversity, the optimal approach is still a matter …

Urinary Tract Resections as Part of Debulking Surgery for Locally Advanced Endometrial Stromal Sarcomas

N Bacalbasa, I Balescu, L Iliescu, C Diaconu, S Dima… - in vivo, 2020 - iv.iiarjournals.org
Background/aim: Although very rare tumors, uterine sarcomas are extremely aggressive
gynecologic malignancies being responsible for a significant number of gynecological …